Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FQ9VM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,118
Award facts
- Contract value 100% obligated
- $14,118.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,118.40 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens with a firm fixed price structure. This delivery order, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award is non-competitive and was not set aside for any specific business category, indicating it was issued directly against an existing contract vehicle. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Dupixent is a biologic medication used to treat atopic dermatitis, asthma, and chronic rhinosinusitis, making this a critical medical supply for defense healthcare systems. AmerisourceBergen's role as a pharmaceutical prime vendor enables the company to supply an extensive portfolio of brand-name and generic drugs, vaccines, and medical supplies to support military healthcare operations worldwide, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FQ9VM?
SPE2DR26FQ9VM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FQ9VM worth?
The government has obligated $14,118 on SPE2DR26FQ9VM.
Is contract SPE2DR26FQ9VM an order under another contract?
Yes. SPE2DR26FQ9VM is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FQ9VM competed?
The extent of competition for SPE2DR26FQ9VM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award